Microsoft Corporation (NASDAQ: MSFT) offers investors a more compelling quantum computing opportunity than IonQ, Inc. (NYSE: IONQ), combining financial firepower with a credible long-term technology roadmap.
Quantum stocks have struggled broadly even as underlying technology continues to advance at a rapid pace.
IonQ, a pure-play quantum company, has seen its shares fall 16.3% over the past three months despite a string of significant technical milestones.
In September alone, IonQ launched its Superion 256 platform, raised its 2026 revenue outlook to $450-$460 million, and announced a deployment at NVIDIA’s (NASDAQ: NVDA) Accelerated Quantum Research Center.
The company also demonstrated real-time quantum error decoding, underscoring the pace at which its technology roadmap is accelerating.
Microsoft, meanwhile, has pursued a fundamentally different path through its Majorana 2 program, which targets scalable topological quantum computing with a practical machine targeted for 2029.
Microsoft opened a Maryland quantum research center and began providing Majorana 2 hardware to DARPA for independent on-site testing, adding a meaningful validation milestone to its program.
MSFT shares have gained 36.5% over the past three months, a sharp contrast to IonQ’s decline over the same period.
IonQ reported $80.1 million in second-quarter 2026 revenues, representing a 287% year-over-year increase driven by quantum-computer deployments, cloud usage and broader commercial activity.
Despite that revenue surge, IonQ posted a $1.87 billion GAAP net loss in the second quarter, while adjusted EBITDA came in at negative $120.3 million.
The company ended June with $3.0 billion in cash, cash equivalents and investments, though that figure drops to approximately $2.0 billion after accounting for cash used in the SkyWater acquisition.
IonQ’s near-term investment case therefore rests primarily on technology milestones, bookings and revenue growth rather than on a path to near-term profitability.
Microsoft’s ability to fund its quantum ambitions stands in stark contrast, with the company generating $55.4 billion in operating cash flow in the fourth quarter of fiscal 2026.
Microsoft ended fiscal 2026 with $20.9 billion in cash and cash equivalents, giving it the balance sheet strength to sustain a lengthy quantum research and development cycle.
Its fiscal 2026 capital expenditures totaled approximately $115.9 billion, directed largely toward cloud and AI infrastructure, with quantum remaining a longer-horizon investment embedded within a diversified business.
On valuation, IonQ trades at a forward price-to-sales multiple of 23.19X, well above the 5.20X multiple for the Computer-Integrated Systems industry, though below its historical median of 61.96X.
Microsoft trades at 9.29X forward sales, compared with 6.13X for the Computer-Software industry and its own historical median of 10.75X, placing its valuation closer to its historical norm.
The Zacks Rank further separates the two stocks, with MSFT carrying a Zacks Rank of 3 (Hold) versus a Zacks Rank of 4 (Sell) for IONQ.
IonQ could offer greater upside sensitivity to any breakthrough in quantum commercialization, but its ongoing losses and premium valuation present a higher risk profile for investors.
Microsoft’s financial strength, diversified revenue base and advancing quantum program make it the more balanced and defensible way to gain quantum exposure heading into October.
